L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons

Cell Calcium

Volumn 46, Issue 5-6, 2009, Pages 303-312

  Hoddah, Hanaa ^b   Marcantoni, Andrea ^a   Comunanza, Valentina ^a   Carabelli, Valentina ^a   Carbone, Emilio ^a  

^a CNISM Research Unit   (Italy)

^b ABDELMALEK ESSAADI UNIVERSITY   (Morocco)

Author keywords

cAMP PKA signal pathway; Cannabinoids; CB1 inverse agonists; Immortalized GnRH neurons; Voltage gated calcium channels

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GONADORELIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE DIPHOSPHATE; GUANOSINE DIPHOSPHATE BETA SUBUNIT; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NIFEDIPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL FUNCTION; CELL IMMORTALIZATION; CELL LEVEL; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HYPOTHALAMUS; INCUBATION TIME; MOUSE; NERVE CELL EXCITABILITY; NERVE POTENTIAL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSATILE HORMONE RELEASE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 70649106886     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.08.007     Document Type: Article

References (61)

1. Hollister L.E. Health aspects of cannabis. Pharmacol. Rev. 38 (1986) 1-20
2. Pertwee R.G. The central neuropharmacology of psychotropic cannabinoids. Pharmacol. Ther. 36 (1988) 189-261
3. Ameri A. The effects of cannabinoids on the brain. Progr. Neurobiol. 58 (1999) 315-348
4. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (2004) 345-358
5. Demuth G., and Molleman A. Cannabinoid signaling. Life Sci. 78 (2006) 549-563
6. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
7. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29 (1986) 307-313
8. Caulfield M.P., and Brown D.A. Cannabinoid receptor agonists inhibit Ca currents in NG108-15 neuroblastoma cells via a pertussis-toxin sensitive mechanism. Br. J. Pharmacol. 106 (1992) 23l-232
9. Mackie K., and Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3825-3829
10. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49 (1996) 707-714
11. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol. Pharmacol. 54 (1998) 1064-1072
12. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., and Childers S.R. Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept. Channels 1 (1993) 121-134
13. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15 (1995) 6552-6561
14. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312 (1995) 637-641
15. Mackie K. Cannabinoid receptors: where they are and what they do. J. Neuroendocr. 20 (2008) 10-14
16. Deadwyler S.A., Hampson R.E., Mu J., Whyte A., and Childers S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273 (1995) 734-743
17. Ho B.Y., Stadnicka A., Prather P.L., Buckley A.R., Current L.L., Bosnjak Z.J., and Kwok W.M. Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells. Endocrinology 141 (2000) 1675-1685
18. Rubovitch V., Gafni M., and Sarn Y. The cannabinoid agonist DALN positively modulates L-type voltage dependent calcium-channels in N18TG2 neuroblastoma cells. Mol. Brain Res. 101 (2002) 93-102
19. 2+ elevations in hippocampal cells. Neuropharmacology 50 (2006) 621-631
20. Straiker A., Stella N., Piomelli D., Mackie K., Karten H.J., and Maguire G. Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14565-14570
21. 2+ channel current. Am. J. Physiol. Heart Circ. Physiol. 276 (1999) 2085-2093
22. Endoh T. Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitaries. Br. J. Pharmacol. 147 (2006) 391-401
23. Hernández-Guijo J.M., Carabelli V., Gandía L., García A.G., and Carbone E. Voltage-independent autocrine modulation of L-type channels mediated by ATP, opioids and catecholamines in rat chromaffin cells. Eur. J. Neurosci. 11 (1999) 3574-3584
24. Baldelli P., Hernández-Guijo J.M., Carabelli V., Novara M., Cesetti T., Andrés-Mateos E., Montiel C., and Carbone E. Direct and remote modulation of L-channels in chromaffin cells: distinct actions on alpha1C and alpha1D subunits?. Mol. Neurobiol. 29 (2004) 73-96
25. Cesetti T., Hernandez-Guijo J.M., Baldelli P., Carabelli V., and Carbone E. Opposite action of beta1- and beta2-adrenergic receptors on Cav1 L-channel current in rat adrenal chromaffin cells. J. Neurosci. 23 (2003) 73-83
26. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., and Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5 (1990) 1-10
27. Gammon C.M., Freeman Jr. G.M., Xie W., Petersen S.L., and Wetsel W.C. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 146 (2005) 4491-4499
28. Van Goor F., Krsmanovic L.Z., Catt K.J., and Stojilkovic S.S. Control of action potential-driven calcium influx in GT1 neurons by the activation status of sodium and calcium channels. Mol. Endocrinol. 13 (1999) 587-603
29. Vazquez-Martinez R., Shorte S.L., Boockfor F.R., and Frawley L.S. Synchronized Exocytotic Bursts from gonadotropin-releasing hormone-expressing cells: dual control by intrinsic cellular pulsatility and gap junctional communication. Endocrinology 142 (2001) 2095-2101
30. Martínez de la Escalera G., and Clapp C. Regulation of gonadotropin-releasing hormone secretion: insights from GT1 immortal GnRH neurons. Arch. Med. Res. 32 (2001) 486-498
31. 2+-dependent gonadotropin-releasing hormone release in GT1-7 cells. Endocrinology 145 (2004) 2375-2383
32. 2+ currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells. Pflugers Arch. Eur. J. Physiol. 457 (2009) 1093-1110
33. Bosma M.M. Ion channel properties and episodic activity in isolated immortalized gonadotropin-releasing hormone (GnRH) neurons. J. Membr. Biol. 136 (1993) 85-96
34. Carbone E., and Lux H.D. A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurons. Nature 310 (1984) 501-502
35. Dolphin A.C. Mechanisms of modulation of voltage-dependent calcium channels by G proteins. J. Physiol. 506 (1998) 3-11
36. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamid. EMBO J. 20 (2001) 7033-7040
37. 9-tetrahydrocannabinol and cannabidiol. J. Biol. Chem. 283 (2008) 16124-16134
38. Twitchell W., Brown S., and Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78 (1997) 43-50
39. Brown S.P., Safo P.K., and Regehr W.G. Endocannabinoids inhibit transmission at granule cell to purkinje cell synapses by modulating three types of presynaptic calcium channels. J. Neurosci. 24 (2004) 5623-5631
40. Catterall W.A., Perez-Reyes E., Snutch T.P., and Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57 (2005) 411-425
41. Ikeda S.R. Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits. Nature 380 (1996) 255-258
42. Marchetti C., Carbone E., and Lux H.D. Effects of dopamine and noradrenaline on Ca channels of cultured sensory and sympathetic neurons of chick. Pflügers Arch. Eur. J. Physiol. 406 (1986) 104-111
43. Bean B.P. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340 (1989) 153-156
44. 2+ channel kinetics by receptor agonists in IMR32 cells. Biophys. J. 70 (1996) 2144-2154
45. Elmslie K.S., Zhou W., and Jones S.W. LHRH and GTP-γ-S modify calcium current activation in bullfrog sympathetic. Neuron 5 (1990) 75-80
46. Fisyunov A., Tsintsadze V., Min R., Burnashev N., and Lozovaya N. Cannabinoids modulate the P-type high-voltage-activated calcium currents in Purkinje neurons. J. Neurophysiol. 96 (2006) 1267-1277
47. Marcantoni A., Baldelli P., Hernandez-Guijo J.M., Comunanza V., Carabelli V., and Carbone E. L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion. Cell Calcium 42 (2007) 397-408
48. Hartzell H.C., Mery P.F., Fischmeister R., and Szabo G. Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature 351 (1991) 573-576
49. 2+ channels in bovine chromaffin cells. J. Physiol. 532 (2001) 73-90
50. Ämmälä C., Ashcroft F.M., and Rorsman P. Cyclic AMP-dependent potentiation of exocytosis in insulin secreting pancreatic cells by stimulation of calcium-influx and direct interaction with the secretory machinery. Nature 363 (1993) 356-358
51. 2+ channel activity and nuclear signaling. Neuron 55 (2007) 261-275
52. Carbone E., Carabelli V., Cesetti T., Baldelli P., Hernandez-Guijo J.M., and Giusta L. G-protein- and cAMP-dependent L-channel gating modulation: a manifold system to control calcium entry in neurosecretory cells. Pflügers Arch. 442 (2001) 801-813
53. 2+ channel signaling complexes in neurons. J. Neurochem. 105 (2008) 573-583
54. i and neuropeptide secretion in immortalized gonadodropin releasing hormone neurons. Neuroendocrinology 61 (1995) 499-508
55. Lee V.H., Lee L.T., and Chow B.K. Gonadotropin-releasing hormone: regulation of the GnRH gene. FEBS J. 275 (2008) 5458-5478
56. Diana M.A., and Marty A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142 (2004) 9-19
57. Chan S.C., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., Meredith G.E., and Surmeier D.J. "Rejuvenation" protects neurons in mouse models of Parkinson's disease. Nature 447 (2007) 1081-1086
58. Jackson A.C., Yao G.L., and Bean B.P. Mechanism of spontaneous firing in dorsomedial suprachiasmatic nucleus neurons. J. Neurosci. 24 (2004) 7985-7998
59. Lupica C.R., and Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 48 (2005) 1105-1116
60. Bean B.P. The action potential in mammalian central neurons. Nat. Rev. 8 (2007) 451-465
61. Mechoulam R., and Shohami E. Endocannabinoids and traumatic brain injury. Mol. Neurobiol. 36 (2007) 68-74